Stockreport

Verastem Oncology to Present Mature RAMP 201 Data in Low-Grade Serous Ovarian Cancer at the International Gynecologic Cancer Society 2024 Annual Meeting

Verastem, Inc.  (VSTM) 
Last verastem, inc. earnings: 10/29 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: verastem.com
PDF Late-breaking abstract of the mature RAMP 201 data evaluating avutometinib plus defactinib in low-grade serous ovarian cancer to be featured as oral plenary presentation [Read more]